News
Median Technologies to Host Two Webcasts and Provide a Company Update on February 2, 2023
Regulatory News:
Median Technologies (ALMDT:PA) (Paris:ALMDT) announced today that Fredrik Brag, CEO and founder of Median Technologies, will provide a company update on February 2nd, 2023 during
GEVELOT S.A.: Weekly report of share buyback January 20 01 2023
Eutelsat Successfully Decommissions EUTELSAT 5 West A Satellite
Regulatory News:
Eutelsat (Paris:ETL):
Initially designed for a 15-year lifetime, the EUTELSAT 5 West A satellite has retired after an impressive 20+ years of fruitful in-orbit operation. The
Median Technologies Announces 2022 Revenue of €23.8 Million, up 16%, and an Order Backlog of €60.8 Million
Regulatory News:
Median Technologies (ALMDT:PA) announces its revenue level for the full year 2022.
“In 2022, revenue generated by the iCRO business continued to grow in double digits. Our new
Dassault Systèmes and IBM Collaborate to Accelerate the Sustainable Transformation of Asset-intensive Industries Thanks to Virtual Twin Experiences
Dassault Systèmes (Paris:DSY) and IBM today announced an extension of their long-standing collaboration with the signature of a memorandum of understanding combining their technologies to address
Die ESI Group bekräftigt ihr Engagement für die Gleichstellung von Mann und Frau am Arbeitsplatz und unterzeichnet die Women’s Empowerment Principles der Vereinten Nationen zur Stärkung von Frauen in Unternehmen
Die ESI Group (ISIN-Code: FR0004110310, Symbol: ESI), ein weltweit operierender Softwarepartner der Industrie für Simulation und virtuelles Prototyping, hat die Women's Empowerment Principles (WEP)
ESI Group Reinforces Its Commitment to Gender Equality at Work and Signs the United Nations Women's Empowerment Principles
Regulatory News:
ESI Group (ISIN Code: FR0004110310, Symbol: ESI), a global simulation and virtual prototyping software partner for the industry, has signed the United Nations Women's Empowerment
Danone-Gruppe beauftragt BALYO mit der Automatisierung eines ihrer Werke mit einer Flotte autonomer «REACHY»-Schubmaststapler
BALYO (FR0013258399, Tickersymbol: BALYO, PEA-PME-qualifiziert), Technologieführer im Bereich Konzeption und Entwicklung innovativer Roboterlösungen für Flurförderzeuge, gibt bekannt, von der
ROCTOOL: STANDEX ENGRAVING AND ROCTOOL SIGN GLOBAL AGREEMENT
ABIONYX Pharma Reports Positive Results from Phase 2a Pilot Clinical Trial Evaluating CER-001 in the Treatment of Septic Patients at High Risk of Developing Acute Kidney Injury
ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today reported that the
BIOSYNEX SA: Extension of the distribution agreement between Credo Diagnostics Biomedical Pte Ltd and BIOSYNEX S.A.
GEVELOT S.A.: Weekly report of share buyback January 12, 2023
Eutelsat Bridging the Digital Divide in Africa by Providing Ubiquitous, Reliable, and Affordable Connectivity Services
Regulatory News:
In June 2022, Eutelsat (Paris:ETL) joined the International Telecommunication Union (ITU) Partner2Connect Digital Coalition. The coalition is a multistakeholder platform
Guerbet: Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under the same price conditions
Valbiotis gibt Roadmap für 2023 bekannt: ein entscheidendes Jahr für die Umsetzung der klinischen, industriellen und kommerziellen Strategie
Aufsichtsrechtliche Meldung:
Valbiotis (FR0013254851 – ALVAL, PEA-KMU-qualifiziert), ein kommerziell orientiertes Forschungs- und Entwicklungsunternehmen mit Schwerpunkt auf wissenschaftlichen
Valbiotis Announces Its Roadmap for 2023: a Pivotal Year in the Execution of Its Clinical, Industrial and Commercial Strategy
Regulatory News:
Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible), a commercially oriented Research and Development company committed to scientific innovation for preventing and combating
RUBIS: Half-year statement on Rubis' liquidity agreement with Exane BNP Paribas
Transgene Receives Approval to Start a Phase I Trial of TG6050, a Novel IL-12-Armed Oncolytic Virus Given by Intravenous Administration
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces it has received
GEVELOT S.A.: Weekly report of share buyback January 5, 2023
Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA
Half-year liquidity contract statement for Sartorius Stedim Biotech
Sensorion Will Take Part in a Press Conference Launching the Annual UNESCO Week of Sound
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
EQS-News: Abivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action
Swisscom erweitert das Vertrauen in Verimatrix VCAS mit vollständiger Migration in die Cloud
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt teilte heute mit, dass Swisscom, ein langjähriger Kunde von
Poxel Announces Upcoming Participation at Investor Conferences
POXEL SA (Euronext: POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including